# U1 Bio, Inc. — Form D

U1 Bio, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-15. The offering totals $650K, of which $450K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-03-15
- Form: D
- Accession: 0001850995-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $650K
- Amount sold: $450K
- Remaining: $200K
- Minimum investment: $25K
- Investors: 9
- Date of first sale: 2021-03-03
- Revenue range: Decline to Disclose
- SEC file number: 021-392266

## Issuer

- Name: U1 Bio, Inc.
- CIK: 0001850995
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 18 BARTOL STREET #966, SAN FRANCISCO, CA, 94133
- Phone: (336) 420-7881

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Konstantinos Charizanis | Director | San Francisco, CA |
| Konstantinos Charizanis | Executive Officer | San Francisco, CA |
| Sharam Seyedin-Noor | Director | Belvedere Tiburon, CA |
| David Nelles | Director | San Francisco, CA |
| David Nelles | Executive Officer | San Francisco, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-06-08](https://search.stillhousedata.com/formd/0001850995-22-000001) | D | $10.7M | $9.5M |

## More

- [CIK 1850995 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1850995&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001850995-21-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.